Table 3 Comparison of viral and/or bacterial infections
Bacteria co-infection | Virus co-infection | Bacteria-Virus co-infection | P value | |
|---|---|---|---|---|
96 (55.17%) | 42 (24.14%) | 36 (20.69%) | ||
Age of onset (day), median (IQR) | 72 (17, 340) | 71.5 (14, 322) | 80 (29, 214) | 0.754 |
Hospital length of stay, median (IQR) | 8 (1, 32) a | 7 (4, 19) b | 10 (3, 32) | 0.115 |
Gender (female, n, %) | 44 (45.8%) | 12 (28.6%) | 18 (50.00%) | 0.100 |
Pertussis Toxin IgG antibodies, IU/ml, median (IQR) | 2.66 (0.00, 219.76) | 10.11 (0.00, 214.95) | 2.57 (0.00, 167.43) | 0.610 |
WBC count, highest cells×103/µL, median (IQR) | 15.41 (5.5, 93.52) c | 12.67 (4.44, 34.63) | 16.03 (7.39, 50.51) | 0.059 |
Lymphocyte count, highest cells×103 /µL, median (IQR) | 10.77 (3.92, 43.95) d | 8.49 (3.15, 24.66) | 12.39 (2.22, 12.39) | 0.096 |
Raised C-reactive protein (n, %) | 13 (13.5%) | 0 (0.00%) | 1 (2.8%) | / |
Raised Procalcitonin (n, %), >0.5 ng/ml | 7 (7.29%) | 0 (0.00%) | 2 (5.56%) | / |
Highest respiratory rate (breaths/min) | 40 (30, 70) | 42 (32, 60) | 43.5 (31, 68) | 0.102 |
Highest heart rate (beats/min) | 130 (112, 168) | 132 (115, 159) | 130 (118, 163) | 0.617 |
Pneumonia (n, %) | 74 (77.1%) | 34 (81.0%) | 34 (86.1%) | 0.505 |
Severe Pneumonia (n, %) | 14 (14.6%) | 5 (11.9%) | 5 (13.9%) | 0.915 |
Respiratory failure (n, %) | 12 (12.5%) | 5 (11.9%) | 5 (13.9%) | 0.964 |